Zevia to Participate in Upcoming Investor Conferences

Zevia PBC (“Zevia” or the “Company”) (NYSE: ZVIA), the company disrupting the liquid refreshment beverage industry with great tasting, zero sugar beverages made with simple, plant-based ingredients, today announced that its Chief Executive Officer, Paddy Spence, and President, Amy Taylor, will participate in two upcoming investor conferences. These include the Goldman Sachs Global Staples Forum, to be held May 17, 2022 in New York, NY and the BMO Global Farm to Market Conference, to be held May 18-19, 2022 in New York, NY.

At the Goldman Sachs Global Staples Forum, Mr. Spence and Ms. Taylor will meet with investors and present at approximately 8:15 a.m. Eastern Time on Tuesday, May 17, 2022. A live webcast of their presentation will be available on the Company’s Investor Relations section of Zevia’s website at https://investors.zevia.com/ during the event.

Additionally, Mr. Spence and Ms. Taylor will meet with investors and present at the BMO Global Farm to Market Conference at approximately 11:00 a.m. Eastern Time on Thursday, May 19, 2022. A live webcast of their presentation will be available on the Company’s Investor Relations section of Zevia’s website at https://investors.zevia.com/ during the event.

Shortly following both events, a replay of each webcast will be available at https://investors.zevia.com/ for approximately thirty (30) days.

About Zevia

Zevia PBC, a public benefit corporation designated as a “Certified B Corporation,” is focused on addressing the global health challenges resulting from excess sugar consumption by offering a broad portfolio of zero sugar, zero calorie, naturally sweetened beverages. All Zevia^® beverages are made with a handful of simple, plant-based ingredients, contain no artificial sweeteners, and are Non-GMO Project verified, gluten-free, Kosher, vegan and zero sodium. As of 2022, Zevia is distributed in more than 31,000 retail locations in the U.S. and Canada through a diverse network of major retailers in the food, drug, mass, natural and ecommerce channels.

(ZEVIA-F)

View source version on businesswire.com: https://www.businesswire.com/news/home/20220513005456/en/